Dr. Atul Gawande is set to become the chief executive of a new health care company being formed by Amazon, Berkshire Hathaway, and JPMorgan Chase.
The company, which has yet to be named, is being launched with lofty ambitions: to find innovative ways to improve health care for employees of the three companies. But its founders have hinted that company-wide solutions could help find solutions to problems across the entire U.S. health system.
Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
I would like to cancel my subscription. How can I do this?
Michael Nussbaum